Calidi BiotherapeuticsCLDI
13F holders, Q3 2025 (September 30)2holders −33
0new positions
32sold out
$1.51avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Calidi Biotherapeutics Inc. (CLDI) in their 13F filings, down 33 from Q2 2025. 0 opened new positions and 32 sold out. The largest holders were Belpointe Asset Management LLC ($32K) and Osaic Holdings, Inc. ($149).
- Company
- Calidi Biotherapeutics Inc.
- CUSIP
- 320703309
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 32 | $590K |
All 13F filers, Q2 2025 → Q3 2025: 2,824,431 shares sold, net −2,824,431 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Belpointe Asset Management LLC | 0.00% | Reduce -91.7% | 20,821 | $32K |
| Osaic Holdings, Inc. | 0.00% | Reduce -99.0% | 253 | $149 |
"% of holder's portfolio" is CLDI's weight in each manager's 13F, not the share of Calidi Biotherapeutics Inc. the manager owns.